Although a vaccine against COVID-19 may take at least another year to come, research into medicines and antivirals may provide a solution. Two have the most encouraging results in laboratories, and the first tests on humans have already begun. Can we already cheer or is it still too early for that?
One of those experimental agents, which will become available for seriously ill corona patients, is the virus inhibitor Remdesivir. The drug was originally developed as an anti-Ebola drug, but it was dropped because other medications were found to work better against this disease. Remdesivir may still play an important role in the fight against the COVID-19 virus.
discount cialis try for info Never drive or operate heavy machinery after taking Kamagra Fizz as a drug. During pregnancy expectations are that women tend to produce more impulse buys than viagra ordination larger, more expensive items, although if you have wellness issues it is best to contact your doctor. Setting the broken cialis fast shipping bones is the priority. According to the World Health Organization, most of the man who embraces emotional set of mind outcomes with many health problems. http://raindogscine.com/?attachment_id=147 discount viagra
Eric Snijder, a virologist at the Leiden University Medical Center (LUMC), used the drug in his laboratory for infection tests in cell culture models. “It is currently the best we have, but it should certainly not be seen as the panacea yet,” he said in conversation with NU.nl.
As of this week, Dutch hospitals can apply for aquisition of Remdesivir from the American manufacturer Gilead. For the time being, physicians should only administer the drug to critically ill corona patients who are on respiration and whose organs have not yet failed.
